Browsing: Biotech

These biotech companies have catalysts ahead.If you’re looking to add a bit of growth to your portfolio, you may turn to well-recognized growth companies that already…

Vamil DivanGuggenheim Securities, LLC, Research Division Thanks so much, everyone, again, for joining us for the second day of our Guggenheim Emerging Outlook: Biotech Summit. I’m…

This article was written byFollowFred Piard, PhD. is a quantitative analyst and IT professional with over 30 years of experience working in technology. He is the…

Biotech stocks have a way of making smart people do dumb things. It starts innocently enough.You read about a “breakthrough” that sounds like it came straight…

Two employees in pharmaceutical industry wearing protective gloves, mask, cap and white suit seen standing by the machine that is the part of the medicaments production…

The massive rotation currently unfolding within ARK Invest suggests that Cathie Wood thinks 2026 will be the definitive coming-out party for the genomic revolution. As 2025 draws…

On the final trading day of 2025, Cathie Wood put an eye-brow raising $1.33 million to work in Intellia Therapeutics (NTLA), scooping up 145,153 shares in…

Major U.S. stock indices closed higher Tuesday, with the Dow Jones Industrial Average up 0.16% at 48,442.41, the S&P 500 advancing 0.46% to 6,909.79, and the…

There are just nine days left in the year, and this year has flown by.We’ve delivered readers a steady stream of 2026 outlooks over the past few…

Although the equities market often embodies chaos and capricious non-linearity, few sectors witness as much kinetic wildness like biotechnology. At its core, biotech represents an innovative…